These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 18036700

  • 1. ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer.
    Lee KH, Min HS, Han SW, Oh DY, Lee SH, Kim DW, Im SA, Chung DH, Kim YT, Kim TY, Heo DS, Bang YJ, Sung SW, Kim JH.
    Lung Cancer; 2008 Jun; 60(3):401-7. PubMed ID: 18036700
    [Abstract] [Full Text] [Related]

  • 2. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.
    Azuma K, Sasada T, Kawahara A, Takamori S, Hattori S, Ikeda J, Itoh K, Yamada A, Kage M, Kuwano M, Aizawa H.
    Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553
    [Abstract] [Full Text] [Related]

  • 3. The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.
    Na II, Rho JK, Choi YJ, Kim CH, Park JH, Koh JS, Ryoo BY, Yang SH, Lee JC.
    Lung Cancer; 2007 Jul; 57(1):96-102. PubMed ID: 17337084
    [Abstract] [Full Text] [Related]

  • 4. Epidermal growth factor receptor gene amplification in surgical resected Japanese lung cancer.
    Sasaki H, Shimizu S, Okuda K, Kawano O, Yukiue H, Yano M, Fujii Y.
    Lung Cancer; 2009 Jun; 64(3):295-300. PubMed ID: 19058870
    [Abstract] [Full Text] [Related]

  • 5. Expression of excision repair cross-complementation group 1 and class III beta-tubulin predict survival after chemotherapy for completely resected non-small cell lung cancer.
    Okuda K, Sasaki H, Dumontet C, Kawano O, Yukiue H, Yokoyama T, Yano M, Fujii Y.
    Lung Cancer; 2008 Oct; 62(1):105-12. PubMed ID: 18395930
    [Abstract] [Full Text] [Related]

  • 6. Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.
    Friboulet L, Barrios-Gonzales D, Commo F, Olaussen KA, Vagner S, Adam J, Goubar A, Dorvault N, Lazar V, Job B, Besse B, Validire P, Girard P, Lacroix L, Hasmats J, Dufour F, André F, Soria JC.
    Clin Cancer Res; 2011 Sep 01; 17(17):5562-72. PubMed ID: 21750204
    [Abstract] [Full Text] [Related]

  • 7. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.
    Brabender J, Danenberg KD, Metzger R, Schneider PM, Park J, Salonga D, Hölscher AH, Danenberg PV.
    Clin Cancer Res; 2001 Jul 01; 7(7):1850-5. PubMed ID: 11448895
    [Abstract] [Full Text] [Related]

  • 8. Expression of ERCC1 and class IIIbeta tubulin for predicting effect of carboplatin/paclitaxel in patients with advanced inoperable non-small cell lung cancer.
    Ikeda S, Takabe K, Suzuki K.
    Pathol Int; 2009 Dec 01; 59(12):863-7. PubMed ID: 20021611
    [Abstract] [Full Text] [Related]

  • 9. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 01; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 10. Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.
    Ohtsuka K, Ohnishi H, Fujiwara M, Kishino T, Matsushima S, Furuyashiki G, Takei H, Koshiishi Y, Goya T, Watanabe T.
    Cancer; 2007 Feb 15; 109(4):741-50. PubMed ID: 17238183
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
    Rusch V, Klimstra D, Venkatraman E, Pisters PW, Langenfeld J, Dmitrovsky E.
    Clin Cancer Res; 1997 Apr 15; 3(4):515-22. PubMed ID: 9815714
    [Abstract] [Full Text] [Related]

  • 12. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC, Chae MH, Lee MH, Kim KM, Lee EB, Kim CH, Park TI, Han SB, Jheon S, Jung TH, Park JY.
    Cancer Genet Cytogenet; 2007 Mar 15; 173(2):107-13. PubMed ID: 17321325
    [Abstract] [Full Text] [Related]

  • 13. [Prognostic significance of ERCC1 mRNA expression in patients with non-small cell lung cancer receiving platinum-based chemotherapy].
    Qian XP, Liu BR, Shi MQ, Liu XZ, Hu WJ, Zou ZY, Wei J.
    Zhonghua Zhong Liu Za Zhi; 2009 Jan 15; 31(1):33-7. PubMed ID: 19538866
    [Abstract] [Full Text] [Related]

  • 14. [EGFR gene copy number, ERCC1 and BRCA1 protein expression and their relationship in non-small cell lung cancer].
    Deng QH, Qiu Y, Mo MC, Zhang X, Xiong XG, Jiang M, He P, Wen DP, Zheng GX, He JX.
    Zhonghua Zhong Liu Za Zhi; 2011 Jul 15; 33(7):508-12. PubMed ID: 22093627
    [Abstract] [Full Text] [Related]

  • 15. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
    Tam IY, Chung LP, Suen WS, Wang E, Wong MC, Ho KK, Lam WK, Chiu SW, Girard L, Minna JD, Gazdar AF, Wong MP.
    Clin Cancer Res; 2006 Mar 01; 12(5):1647-53. PubMed ID: 16533793
    [Abstract] [Full Text] [Related]

  • 16. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
    Mounawar M, Mukeria A, Le Calvez F, Hung RJ, Renard H, Cortot A, Bollart C, Zaridze D, Brennan P, Boffetta P, Brambilla E, Hainaut P.
    Cancer Res; 2007 Jun 15; 67(12):5667-72. PubMed ID: 17575133
    [Abstract] [Full Text] [Related]

  • 17. Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype.
    Tseden-Ish M, Choi YD, Cho HJ, Ban HJ, Oh IJ, Kim KS, Song SY, Na KJ, Ahn SJ, Choi S, Kim YC.
    Respirology; 2012 Jan 15; 17(1):127-33. PubMed ID: 21899657
    [Abstract] [Full Text] [Related]

  • 18. Influence of epidermal growth factor receptor (EGFR) gene mutations on the expression of EGFR, phosphoryl-Akt, and phosphoryl-MAPK, and on the prognosis of patients with non-small cell lung cancer.
    Sonobe M, Nakagawa M, Takenaka K, Katakura H, Adachi M, Yanagihara K, Otake Y, Wada H, Tanaka F.
    J Surg Oncol; 2007 Jan 01; 95(1):63-9. PubMed ID: 17192868
    [Abstract] [Full Text] [Related]

  • 19. Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients.
    Murray S, Timotheadou E, Linardou H, Vrettou AV, Kostopoulos I, Skrickova J, Papakostantinou C, Christodoulou C, Pectasides D, Samantas E, Papakostas P, Skarlos DV, Kosmidis P, Fountzilas G.
    Lung Cancer; 2006 May 01; 52(2):225-33. PubMed ID: 16567021
    [Abstract] [Full Text] [Related]

  • 20. Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literature.
    Vilmar A, Sørensen JB.
    Lung Cancer; 2009 May 01; 64(2):131-9. PubMed ID: 18804893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.